Soluble P-selectin and Correlation with Prothrombin Fragment 1+2 in Myeloid Malignancies in Cipto Mangunkusumo General Hospital
Abstract Background Patients with hematological malignancies carry increased risk of cancer-associated thrombosis and adhesion molecule plays an important role in the mechanism of thrombus formation. The study aimed to evaluate the soluble P-selectin and prothrombin fragment 1 + 2 (F1 + 2) and to determine the correlation of sP-selectin with leukocyte count and F1 + 2 levels in acute myeloid leukemia (AML) and chronic myeloid leukemia (CML) patients. Methods A cross-sectional study of newly diagnosed AML and CML patients, aged 18 years or older. The exclusion criteria were pregnancy, severe infection, immobilization for at least 3 days or during intensive chemotherapy. Controls were healthy people, without anticoagulant and/or antiplatelet medication. Complete blood count was measured by ABX Micros 60®, and sP-selectin and F1 + 2 levels were determined using Behring ELISA Processor-III® and Behring Enzygnost F1 + 2. Results A total of 55 subjects, consisted of 25 AML and 13 CML patients and 17 controls. Soluble P-selectin was significantly elevated in AML patients compared to CML patients (median 0.14 vs 0.25 ng/mL, p = 0.001). Levels of F1 + 2 in AML (median 519.03 pmol/L) and CML patients (median 370.16 pmol/L) were significantly increased compared to controls (p < 0.001 and p = 0.043). Soluble P-selectin were significantly correlated to leukocyte count (R = 0.437; p = 0.029) and F1 + 2 (R = 0.436; p = 0.029) in AML, but not in CML patients. Conclusions AML and CML patients had increased expression of sP-selectin and coagulation activation. While CML patients had higher sP-selectin, AML patients had the highest state of hypercoagulability. Soluble P-selectin was correlated with leukocyte count and F1 + 2 in AML patients.